CANJI has a total of 13 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Czechia, Hungary and Poland. Its main competitors in its focus markets pharmaceuticals and biotechnology are HEART BIOSYSTEMS GMBH, GLYCOSTEM THERAPEUTICS B V and OXFORD BIOMEDICA LTD.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Maneval Daniel C | 5 |
#2 | Gregory Richard J | 4 |
#3 | Shabram Paul W | 3 |
#4 | Wills Ken N | 3 |
#5 | Ramachandra Muralidhara | 3 |
#6 | Resnick Gene | 2 |
#7 | Nielsen Loretta | 2 |
#8 | Nagabhushan Tattanahalli L | 2 |
#9 | Rybak Mary Ellen | 2 |
#10 | Horowitz Jo Ann | 2 |
Publication | Filing date | Title |
---|---|---|
HU9903864A2 | Nucleic acids coding for ezf-rb fusion polypeptides and expression vectors containing the same | |
HU9600396D0 | Prostate tumor suppressor gene located on human chromosome | |
UA70909C2 | Recombinant adenovirus expression vector, pharmaceutical composition, and gene therapy aimed at inhibiting cancer cell proliferation |